The Promoting Resources to Expand Vaccination, Education and New Treatments for HPV Cancers Act of 2025 adds a national HPV cancer prevention public awareness campaign to the Public Health Service Act. The campaign, run by the CDC, aims to increase HPV vaccination rates, combat misinformation, and improve public understanding of HPV-related cancers.
It directs targeted outreach to communities with higher risk and lower vaccination rates, and it authorizes grants to nonprofits to develop culturally competent materials and implement outreach in partnership with health, education, and community groups. In addition, the bill expands funding for the Breast and Cervical Cancer Early Detection Program to support screening access and coordination through 2030, and updates the coordinating framework to reflect longer-term planning.
Taken together, the bill formalizes a federal push to boost vaccination and early detection as a cancer-prevention strategy, prioritizing underserved communities, providers, and institutions that touch adolescents and young adults. The funding and coordination changes signal a sustained commitment to prevention alongside screening, education, and equitable access.
This matters for healthcare systems, public health departments, schools, and community organizations that will be involved in outreach and program delivery.
At a Glance
What It Does
Creates a national HPV cancer prevention public awareness campaign administered by the CDC under Section 317, focused on increasing vaccination, countering misinformation, and improving vaccine series completion.
Who It Affects
Public health departments, healthcare providers, nonprofits implementing campaigns, and communities with high HPV risk (including rural populations and Black and Hispanic women), plus active-duty service members and veterans.
Why It Matters
Addresses the burden of HPV-related cancers and disparities in vaccination and screening, and coordinates outreach with existing cancer prevention initiatives to maximize impact.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill adds an HPV cancer prevention public awareness campaign to the Public Health Service Act, run by the CDC. The campaign is designed to raise awareness about HPV vaccination, counter misinformation about vaccines, and boost vaccination rates.
It requires collaboration with expert organizations, public health departments, schools, and higher education institutions to tailor materials for communities most affected by HPV-related cancers, including rural populations and racial/ethnic minority groups. The campaign may use social media, traditional media, in-person outreach, and trusted public figures to disseminate messages and resources to health-care providers and facilities that administer vaccines.
Key features include message testing to refine culturally appropriate communications and grants or cooperative agreements to nonprofits to deliver the campaign at the community level. The act also includes reporting requirements and coordination with other federal HPV efforts, ensuring that messaging aligns with screening and prevention programs.
In parallel, the law expands funding for the Breast and Cervical Cancer Early Detection Program to $300 million annually from 2026 through 2030 and updates the coordinating committee’s timeframe to 2030, signaling a broader strengthening of cancer prevention and early-detection infrastructure.
The Five Things You Need to Know
The bill creates a new HPV cancer prevention public awareness campaign under Section 317, led by the CDC.
Campaigns must be evidence-based, funded via competitive grants to nonprofit organizations, and culturally tailored for target communities.
Dissemination includes outreach to providers and health facilities, plus coordination with existing federal HPV efforts.
Funding for the awareness campaign is authorized at $5 million per year from 2026 through 2030.
Breast and Cervical Cancer Early Detection Program funding increases to $300 million per year for 2026–2030, with a revised coordinating timeline to 2030.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Findings and Rationale for HPV Cancer Prevention
The findings establish the public health rationale for the act: HPV causes multiple cancers (anal, cervical, oropharyngeal, penile, vaginal, vulvar); roughly 39,300 cancers are HPV-related each year; cervical and anal cancers are predominantly HPV-driven; disparities in screening and vaccination exist, especially affecting Black and Hispanic women and rural populations; vaccination is most effective when given at ages 9-12, though licensed through age 45; vaccination rates among adolescents lag behind other vaccines; provider recommendations strongly influence uptake. These findings frame the need for a federally coordinated awareness and prevention effort that targets high-burden communities and reinforces vaccination as a primary prevention tool.
HPV Cancer Prevention Public Awareness Campaign — General Authority
Adds a new subsection to Section 317 expanding the Public Health Service Act to authorize a national HPV cancer prevention public awareness campaign. The Secretary, via the CDC Director, must carry out the campaign to promote HPV vaccination, counter misinformation, and increase vaccination rates. The campaign is designed to be evidence-based, outreach-driven, and coordinated with other federal efforts in HPV prevention and cancer screening.
Consultation and Collaboration
The Secretary must consult with the National Academy of Medicine (NAM), health care providers, public health associations, nonprofits representing affected communities, state and local health departments, education organizations, and higher education institutions. The goal is to gather advice on effective policy and program development, implementation, and evaluation to inform the campaign.
Campaign Requirements
The campaign must use evidence-based media and public engagement and be carried out via competitive grants or cooperative agreements to one or more nonprofit entities with a track record in similar campaigns. It must develop culturally and linguistically competent resources tailored to high-risk groups (including Black and Hispanic women, rural communities, and military populations), disseminate information to providers and facilities, coordinate with other federal HPV efforts, include message testing for cultural effectiveness, and award grants to state/local/Tribal public health departments to engage communities and support local dissemination.
Dissemination and Targeting
Dissemination may use social media, TV, radio, print, the internet, and in-person engagements. Messages shall be targeted to the specified communities and must highlight vaccination age ranges, benefits of vaccination, and vaccine safety and monitoring systems.
Appropriations for Campaign
Authorization of $5,000,000 for each fiscal year 2026–2030 to carry out the HPV cancer prevention campaign.
Breast and Cervical Cancer Early Detection Program Funding
Amends the program funding by replacing the old baseline with $275,000,000 for FY2012 plus $300,000,000 for each FY 2026–2030, effectively increasing annual funding to $300 million through 2030.
Coordinating Committee Timeline
Updates the coordinating committee’s planning horizon from the 2020 target to 2030, aligning coordination efforts with the expanded prevention and detection initiatives.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- State and local public health departments gain resources and flexibility to implement targeted HPV outreach and measure impact.
- Public health and medical professional associations benefit from standardized, evidence-based messaging and collaboration opportunities.
- Nonprofit organizations with HPV/cancer prevention missions receive grant funds to execute campaigns and expand reach.
- Communities with high HPV burden (notably Black and Hispanic women and rural populations) gain improved access to information and vaccination opportunities.
- Active-duty service members and veterans receive targeted messaging and resources relevant to their health needs.
- Educational institutions (K-12 and higher education) participate in outreach and dissemination channels to reach students and parents.
Who Bears the Cost
- Federal government (HHS/CDC) funds the new campaign and related evaluation efforts.
- State and local public health departments incur administrative and outreach costs to implement campaign activities.
- Nonprofit grant recipients bear program implementation costs and reporting requirements.
- Healthcare providers may incur time costs to integrate campaign messaging into routine care and patient education blocks.
Key Issues
The Core Tension
Balancing a national, culturally competent HPV vaccination message with a finite, annually appropriated budget while coordinating with existing screening and prevention efforts to maximize impact in diverse communities.
The bill’s approach relies on a modest annual appropriation ($5 million) to drive a nationwide public awareness effort, while substantial programmatic expansion targets the Breast and Cervical Cancer Early Detection Program. This creates tensions between breadth of reach and depth of impact, particularly in underserved communities where vaccine uptake remains low.
The success of the campaign will hinge on effective collaboration with trusted community partners, rigorous evaluation, and avoidance of messaging fatigue or misalignment with other preventive services. There is also a tension between messaging campaigns and the broader policy environment around vaccination mandates and school-based vaccination programs, which could shape how campaigns are received at the local level.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.